Stock of Sun Pharmaceutical Industries reached at pinnacle on the NSE stocks, rising up by 7.39% at Rs. 606.50.
Leading drug major, Sun Pharmaceutical Industries Limited (Sun Pharma), as per the stock exchange filing, reported a net profit of Rs 983.00 crore for the quarter April-June, against a loss of Rs 425.00 crore in the corresponding period last year.
The drug-maker’s revenue for the quarter spiked by 16% on a Y-o-Y basis to Rs 7,224 crore, whereas other returns was up by 31% to Rs 199 crore from last year. The EBITDA for the quarter under review jumped by 47% to Rs 1,607 crore, at the same time margin expanded 460 bps to 22.2%.
After the result announcement, shares of Sun Pharma reached at pinnacle on the NSE stocks, rising up by 7.39% at Rs. 606.50. On the BSE also, Sun Pharma stocks reached at top by 6.91% up quoting Rs. 601.65.